Fucidin cream
Fucidin cream Price range: $ 14,00 through $ 73,00
Back to products
Furazolidone
Furazolidone Price range: $ 6,00 through $ 27,00

Fulvicin

Price range: $ 25,00 through $ 160,00

Fulvicin is a specialized antifungal medication designed to combat various fungal infections of the skin, hair, and nails. The active ingredient works by inhibiting fungal cell division, effectively stopping the spread of the infection at its source. It is particularly effective for treating common conditions such as ringworm, athlete’s foot, and persistent scalp infections. This treatment is often utilized for stubborn nail fungus that requires a systemic approach to achieve clear results. By supporting the growth of healthy, uninfected tissue, Fulvicin helps restore the natural condition of the skin and its appendages.

Active substance: Griseofulvin
SKU: Fulvicin Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Fulvicin belongs to a class of systemic antifungal medications prescribed for treating superficial fungal infections of the skin, hair, and nails. This oral agent is utilized when localized topical antifungal formulations are inadequate or when fungal elements infect keratinized tissues such as deep hair follicles and nail beds.

Dispensed in accordance with applicable federal and state prescription regulations in the United States, Fulvicin requires clinical evaluation and prescription by a licensed healthcare provider. Diagnostic confirmation, such as a microscopic examination or fungal culture, is routinely recommended before therapy is initiated.

Attribute Details
Drug name Fulvicin
Active ingredient (INN) Griseofulvin
Therapeutic class Systemic antifungal agent
Dosage form Oral tablet / oral suspension
Route of administration Oral
Prescription status Prescription medication (Rx)
Primary purpose Treatment of dermatophytic fungal infections

Clinical Overview and Pharmacologic Profile

How the drug works: Fulvicin acts directly on susceptible dermatophyte fungi by disrupting their internal cell division processes. The active substance, griseofulvin, binds to fungal tubulin proteins, interfering with the assembly and function of the mitotic spindle apparatus. This inhibition arrests cell division at metaphase, preventing fungal growth and replication. Following systemic absorption, griseofulvin selectively deposits into keratin precursor cells in the epidermis, hair follicles, and nail matrices. As new keratinized tissue forms, it remains resistant to fungal invasion. The pre-existing infected skin or nail tissue eventually sloughs off and is replaced by healthy, non-infected tissue.

Main uses: Fulvicin is indicated for the management of ringworm infections caused by susceptible species of dermatophytes, including members of the Trichophyton, Microsporum, and Epidermophyton genera. Specific FDA-approved indications include tinea capitis (scalp ringworm), tinea corporis (body ringworm), tinea cruris (jock itch), tinea pedis (athlete’s foot), and tinea unguium (onychomycosis or fungal nail infection). Fulvicin is ineffective against bacterial infections, candidiasis (yeast infections), or deep systemic fungal diseases such as histoplasmosis or blastomycosis. Use of Fulvicin for non-dermatophytic skin conditions, such as lichen planus, represents an off-label application and requires strict clinical oversight.

What happens in the body: The gastrointestinal absorption of Fulvicin is variable and depends on formulation micro-sizing and dietary intake. Administering the drug alongside high-fat meals significantly enhances its dissolution and systemic bioavailability. Following oral administration, peak plasma concentrations are reached within 4 to 8 hours. Griseofulvin concentrates predominantly in the stratum corneum of the skin, nail plates, and hair shafts. Metabolism occurs primarily in the liver via oxidative demethylation and glucuronidation. The elimination half-life ranges between 9 and 24 hours in adult patients. Inactive metabolites are excreted primarily through the urine, with residual amounts eliminated through feces and perspiration.

Administration, Safety, and Patient Guidance

Dosing Schedule and Administration

The total daily dosage of Fulvicin is determined individually by a licensed prescriber based on the patient’s body weight, the target fungal pathogen, and the anatomical location of the infection. Oral doses may be administered as a single daily dose or divided into multiple daily doses. Therapy duration must align with the natural growth rate of the affected tissue: body skin infections generally require 2 to 4 weeks of continuous treatment; scalp infections require approximately 4 to 6 weeks; fingernail infections demand a minimum of 4 months; and toenail infections often require 6 to 12 months of continuous therapy. Discontinuing treatment before full tissue regeneration occurs increases the risk of infection relapse.

Adverse Reactions and Important Precautions

Adverse effects associated with Fulvicin range from mild gastrointestinal symptoms to serious systemic reactions. Central nervous system effects include headaches, which frequently manifest during early therapy and often diminish with continued use. Gastrointestinal disturbances include nausea, vomiting, epigastric distress, and diarrhea. Dermatologic effects include cutaneous hypersensitivity reactions, urticaria, and pronounced photosensitivity. Severe precautions include the following clinical risks:

  • Hepatotoxicity: Elevated liver enzymes, jaundice, or hepatitis can occur; periodic liver function tests are indicated during prolonged therapy.
  • Hematologic toxicity: Granulocytopenia and leukopenia have been documented; routine blood counts are recommended during long-term administration.
  • Severe skin reactions: Rare instances of toxic epidermal necrolysis or erythema multiforme require immediate discontinuation of therapy.
  • Absolute contraindications: Fulvicin is contraindicated in individuals with porphyria, severe hepatic failure, or known hypersensitivity to griseofulvin.

Compatibility with Other Medicines

Fulvicin acts as an inducer of hepatic cytochrome P450 enzymes, leading to clinically significant interactions when co-administered with other pharmaceutical agents. Key drug interactions include:

  • Oral Anticoagulants (e.g., Warfarin): Fulvicin may decrease the anticoagulant response by increasing hepatic metabolism of warfarin. Prothrombin time or International Normalized Ratio (INR) monitoring is necessary, and anticoagulant doses may require adjustment.
  • Oral Contraceptives: Concurrent use of estrogen-containing or progestin-only birth control pills with Fulvicin can decrease contraceptive efficacy, resulting in breakthrough bleeding or unintended pregnancy. Alternative non-hormonal contraception methods should be utilized during treatment and for one month following discontinuation.
  • Barbiturates: Phenobarbital and other barbiturates decrease the gastrointestinal absorption of griseofulvin, potentially diminishing its therapeutic effectiveness.

Food and alcohol interactions: Administration with high-fat meals improves drug absorption and systemic bioavailability. Conversely, alcohol consumption during Fulvicin therapy should be avoided. Griseofulvin can alter alcohol metabolism, precipitating a disulfiram-like reaction characterized by facial flushing, rapid heartbeat, nausea, sweating, and throbbing headache.

If you skip a dose: If a dose is missed, it should be taken as soon as remembered on that day with food. However, if it is near the time for the next scheduled dose, the missed dose should be skipped and the regular schedule resumed. Patients should not double the dose to compensate for a missed tablet.

Storage and expiration: Store Fulvicin at controlled room temperature between 68°F and 77°F (20°C to 25°C). Keep the container tightly closed, away from excess heat, moisture, and direct sunlight. Do not store in humid environments like bathrooms. Store safely out of reach of children and pets. Properly discard any expired medication.

Practical tips: Proper hygiene practices complement systemic therapy. Keep the affected skin clean and dry, wear breathable cotton garments, and change socks daily for foot infections. Avoid sharing towels, combs, or footwear to eliminate reinfection risks in residential settings.

Common Questions (FAQ)

Why is a long course of treatment necessary for fungal nail infections?

Fulvicin does not immediately destroy fungus already established within the hard nail plate. Instead, it prevents fungal invasion of new nail cells forming at the base. Complete resolution requires the infected nail to grow out entirely, which takes several months for fingernails and up to a year for toenails.

Can I drink alcohol while taking Fulvicin?

Alcohol should be avoided during treatment. Griseofulvin can interact with alcohol to cause severe flushing, rapid heart rate, nausea, and headache, similar to a disulfiram reaction.

Does Fulvicin interfere with hormonal birth control?

Yes. Fulvicin accelerates the breakdown of synthetic hormones in oral contraceptives, which reduces their effectiveness. Additional non-hormonal barrier methods of birth control should be used throughout therapy and for at least four weeks after stopping the medication.

What precautions should I take regarding sun exposure?

Fulvicin increases cutaneous sensitivity to ultraviolet light. Exposure to direct sunlight or tanning equipment can trigger severe sunburns or skin rashes. Using broad-spectrum sunscreen and wearing protective clothing outdoors is strongly advised.

Are routine blood tests required while taking this drug?

For patients undergoing extended courses of therapy (exceeding 30 days), healthcare providers routinely monitor liver function, kidney parameters, and complete blood counts to check for potential systemic adverse effects.

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

250 mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

360 pills

Ενεργός Ουσία